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Psychosocial, emotional, and physical problems can emerge after traumatic brain injury (TBI), potentially impacting health-related
quality of life (HRQoL). Until now, however, neither the discriminatory power of disease-specific (QOLIBRI) and generic (SF-36)
HRQoL nor their correlates have been compared in detail. These aspects as well as some psychometric item characteristics
were studied in a sample of 795 TBI survivors. The Shannon H󸀠 index absolute informativity, as an indicator of an instrument’s
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power to differentiate between individuals within a specific group or health state, was investigated. Psychometric performance of the
two instruments was predominantly good, generally higher, and more homogenous for the QOLIBRI than for the SF-36 subscales.
Notably, the SF-36 “Role Physical,” “Role Emotional,” and “Social Functioning” subscales showed less satisfactory discriminatory
power than all other dimensions or the sum scores of both instruments. The absolute informativity of disease-specific as well as
generic HRQoL instruments concerning the different groups defined by different correlates differed significantly. When the focus
is on how a certain subscale or sum score differentiates between individuals in one specific dimension/health state, the QOLIBRI
can be recommended as the preferable instrument.
1. Introduction
After traumatic brain injury (TBI) patients often experience
important physical progress within the first six months
of recovery. However, cognitive and psychosocial problems
continue to persist for the majority of individuals with severe
TBI [1]. Patients who have suffered from moderate TBI also
report a similar pattern of recovery. Yuh et al. [2] found
in their study on individuals after TBI that poorer outcome
in physical recovery after three months was associated with
abnormalities in MRI, after adjusting for demographic, clini-
cal, and socioeconomic factors. Other imaging studies have
described that psychological disorders, such as PTSD, are
associated with changes in brain structure [3].
In the past 20 years researchers have reiterated that
physical, psychological, and social constraints following TBI
present a major challenge to the patients’ rehabilitation
and their reintegration into society. It has been known in
the context of other conditions affecting the brain, such
as epilepsy [4], that these factors can exert considerable
influence on theHRQoL of patients. Compared to other fields
of neurology, research into HRQoL in TBI has only quite
recently gained momentum. HRQoL measures capture the
patient’s own perspective as the best expert of his or her
wellbeing and HRQoL. Earlier assumptions that individuals
having suffered a TBI would not be able to adequately rate
their own HRQoL have more recently been challenged. Now
a significant number of studies in TBI successfully employed
HRQoL approaches [5].
HRQoL assessment combines multiple domains includ-
ing physical, psychological (emotional, cognitive), Social,
and Daily Life aspects [6]. Measurement of generic HRQoL
allows for a comparison across disease states and populations.
However, generic tools may not be particularly sensitive for
specific aspects and sequelae of a defined disease or health
condition. Disease-specific measurement of HRQoL, on the
other hand, identifies and targets meaningful, disease- and
condition-specific aspects and may therefore be more sensi-
tive to the impacts of the patient’s specific health condition.
HRQoL assessment can provide standardized informa-
tion on recovery patterns and frequency over time, on
associations with correlates of disabilities, and on restrictions
of wellbeing as viewed from the patient’s perspective [6].
Another approach is the use of item banks such as PROMIS
[7] and Neuro-QOL [8], which are based on probabilistic
measurement models replacing individual instruments and
assuring generic and specific evaluation, with the possibility
of cross-disease comparability. The application of these sys-
tems in TBI is yet still rare [9–11].
It has been evidenced in a number of studies on generic
HRQoL that patients afflicted by TBI suffer from a dete-
rioration of HRQoL across all severity degrees [5, 12, 13].
Among the publications using generic HRQoL assessment,
the SF-36 health survey is the most widely administered
self-rating questionnaire [5]. Overall, studies using the SF-36
have found lower mean scores on all of its eight scales (see
below), and on theMental Component Summary (MCS) and
Physical Component Summary (PCS) score for patients with
TBI compared with control groups, reflecting poorer health
[14, 15].
In disease-specific measurement of HRQoL after TBI the
QOLIBRI is the first instrument developed simultaneously in
multiple languages. To date there are over 10 studies published
reporting on the development and psychometric qualities of
the QOLIBRI in TBI populations [6, 16–19] and a number of
papers on the application of the QOLIBRI in clinical contexts
[20–22]. However, no publication yet has been identified
presenting a comprehensive comparison of disease-specific
and generic HRQoL after TBI.
A large number of studies have found that sociodemo-
graphic characteristics and clinical symptoms are associated
with HRQoL, suggesting that the impact of neurological
deficits and a changed life situation may lead to poorer
HRQoL after TBI [15, 23–27]. Studies also indicate that
depression, anxiety, and functional disability have a detri-
mental effect on HRQoL after TBI [1, 17, 28, 29]. In addition,
Sta˚lnacke [25] described that a large proportion of individuals
after mild TBI experienced both postconcussion symptoms
and psychosocial difficulties, combined with low levels of
life satisfaction three years after TBI. Furthermore, elapsed
time since injury has been found to also have an impact on
generic HRQoL [23]. Results however are not unequivocal;
Andelic et al. [30] found no association between HRQoL
and functional competence or Employment Status of TBI
patients. One paper however briefly examined differences
between a disease-specific tool (QOLIBRI) and a generic tool
(SF-36) inspecting the associations of the summary scores of
the two instruments with the GOSE [17]. Authors concluded
thatHRQoL assessedwith the SF-36 is generally captured also
by the QOLIBRI but that there is also additional information
available from QOLIBRI scores which was not provided by
the SF-36. This study will investigate and compare in detail
correlates specific for generic versus disease-specific HRQoL.
Concerning compliance with classical psychometric cri-
teria, validity and reliability of both, the QOLIBRI [16, 17]
and SF-36 after TBI [31, 32], have been proven elsewhere.
Differences do exist in the QOLIBRI and SF-36 in conceptu-
alization of subjective health, in inclusion ofHRQoLdomains
and items, and in the algorithms used to derive summary
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scores. Differences in assessing HRQoL in a disease-specific
or a generic fashionmight have the undesirable effect that the
distinct instruments yield different results for similar health
states. Furthermore which instrument provides the most
solid outcomes with respect to understanding interindividual
differences in scale scores is not yet understood. Thus this
paper aims at the examination of the discriminative power
within a comprehensive sample of TBI patients.
Usually the comparison of HRQoL after TBI determined
with a generic [31, 32] and a disease-specific instrument [16,
17] is based on classical psychometric criteria, in which the
concepts of reliability, validity, sensitivity, and responsiveness
are characterized by the ability to distinguish between “true”
different levels of health/HRQoL states [33]. In the study
presented here a different approach is applied, the Shannon
index 𝐻󸀠. It originates from the field of information theory
but can be applied to any classification, including health
classifications andHRQoL systems such as the SF-36, the EQ-
5D [34], and theQOLIBRI.The index𝐻󸀠 translates the differ-
ence between individuals in a given health domain/subscale
of an instrument into discriminative power [24, 35]. It also
captures a complementary aspect of reliability which cannot
be analysed sufficiently when solely investigating consistency
coefficients [34].
To gain insight into the diversity of patients the two
instruments are able to detect, the current paper analysed
the absolute informativity of the QOLIBRI and SF-36 sum
scores and subscales. By absolute informativity, we mean the
degree to which certain characteristics are distributed among
a specific group. If, for example, in a question on educational
background with four response options 25% of the sample
chooses one option each, high informativity or diversity is
detected. However, if 75% of the sample chooses one option
and the remaining 25% chooses the other options, informa-
tivity of these characteristics with regard to the specific group
is low. Furthermore, to be able to investigate whether disease-
specific and generic HRQoL are correlated with similar vari-
ables, as this may explain variation in discriminative power
(𝐻󸀠), the QOLIBRI Total score and SF-36 MCS and PCS as
outcomes and a number of sociodemographic, psychosocial,
and health-related variables as predictors (correlates) were
analysed via a stepwise linear regression analysis. (In this
paper, in view of terminology differing between disciplines
the term correlate is applied instead of the psychometrically
correct term predictor.)
2. Methods
2.1. Participants. The study sample was recruited in six
languages (The Netherlands, UK/USA, Finland, France, Ger-
many, and Italy). Data from this patient sample was also
published in von Steinbu¨chel et al. [16, 17]. Around 45% of
the patientswere in outpatient treatment during participation
in our study, and the other did not receive any treatment
during the assessment. Inclusion criteria entailed the follow-
ing: ICD-10 diagnosis of TBI, minimum age at injury of 15
years, 17–68 years of age at interview, outpatient treatment
(currently not admitted to a ward), and ability to provide
informed consent. By the inclusion criterion “outpatient
treatment” the exclusion of patient being currently admitted
to a ward was intended. Exclusion criteria were as follows:
a Glasgow Outcome Score Extended (GOSE) [36] below
3, serious current or preinjury psychiatric issues, current
severe addiction, diagnosis of a terminal illness, inability
to cooperate in the study, and incapability to understand
and answer the questions. Patients were asked in a clinical
interview and/or records were checked whether they were
ever given a psychiatric or addiction diagnosis. If this was
the case, their participationwas rejected. Ethics clearancewas
available from each of the recruiting centers.
2.2. Medical Information
2.2.1. Clinical Information Checklist. Professionals filled in a
checklist which asked for information regarding the patient’s
clinical background, such as TBI diagnosis, Severity of TBI,
current age, age at the time of injury, time since injury,
interviewmode, and outpatient status. Furthermore, patients’
worst GCS score (24 h after injury) was reported as well
as the presence of spinal cord injury, current or preinjury
psychiatric problems, drug/alcohol dependence, terminal
illness, and understanding and communication abilities.
2.2.2. Self-Reported Health-Status List [37]. This question-
naire consisted of a list of 29 symptoms and possible
ComorbidHealthConditionswith a binary (yes/no) response
scale. Three subscales were computed for further analysis:
comorbidity (with items on allergies, asthma, thyroid issues,
diabetes, back problems, arthritis, high blood pressure, heart
disease, angina pectoris, heart attack, use of a pacemaker,
bowel inflammation, ulcer, kidney disease, and cancer),
sensory/psychosomatic complaints (discomfort with smell,
vision, hearing, sleep, headache, nervousness, depression,
lack of energy, and lack of physical strength), and muscu-
loskeletal complaints (including problems with movement,
paralysis or neurological problems due to TBI, or other than
TBI, and amputation of a limb).
2.2.3. Glasgow Coma Scale (GCS) [38]. The Glasgow Coma
Scale is a measure of the depth and duration of consciousness
impairment and coma. It assesses motor responsiveness, ver-
bal performance, and eye opening and it ultimately classifies
brain injury into mild (GCS 13–15), moderate (GCS 9–12),
and severe (GCS 3–8).The participants’ 24 h postinjury worst
GCS score was obtained from medical records.
2.2.4. Glasgow Outcome Scale Extended (GOSE) [36]. This
tool determines the grade of disability and recovery con-
cerning the functional status of a patient. For analyses we
applied a 3-level categorization of severe disability (GOSE
3-4), Moderate Disability (GOSE 5-6), and good recovery
(GOSE 7-8).
2.2.5. Hospital Anxiety and Depression Scale (HADS) [39].
The patient’s anxiety and depression levels were self-rated;
scores of 8 to 10 represent mild symptoms, 11 to 15 moderate
symptoms, and ≥16 severe symptoms [40].
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2.3. Sociodemographic Data
2.3.1. Sociodemographic and Patient Questionnaire. Partici-
pants’ Gender, Age, Relationship Status, time since injury,
Education, former and current Employment Status, and
Living Arrangement were recorded as well as self-perceived
Independence, Leisure and Social Activities, and self-
perceived health in the past 6 months. Furthermore, the
amount of reliance on other people’s help (Help Needed) was
assessed covering basic personal needs, mobility, daily activ-
ities, transportation and organization, and “management of
things” in life. Participants were asked to respond on a Likert
scale from 1 (“no help needed”) to 5 (“constant help needed”).
2.4. Disease-Specific and Generic HRQoL Instruments
2.4.1. Quality of Life after Brain Injury (QOLIBRI) Scale [16,
17]. This disease-specific HRQoL instrument consists of 37
items associated with six subscales including Cognition, Self,
Daily Life and Autonomy, Social Relationships, Emotions,
and Physical Problems. The first four subscales inquire about
the participant’s “satisfaction” with different health-related
domains of quality of life. The last two subscales ask about
how much the participant felt “bothered by” a variety of
issues. Answers are given on a 5-point Likert scale that
ranges from “not at all,” “slightly,” “moderate,” and “quite”
to “very.” The scale means are converted to the 0–100% scale
by subtracting 1 from the mean and then multiplying by 25.
This produces scale scores with a lowest possible value of 0
(worst possible HRQoL) and a maximum value of 100 (best
possible HRQoL). The QOLIBRI provides a disease-specific
HRQoL profile over six domains in addition to a total score.
Depending on the participant’s background, the recruiting
centers administered the appropriate language version of the
QOLIBRI.
2.4.2. SF-36 Health Survey Version 1 [41]. To capture the
patients’ subjective health status SF-36 version 1 was admin-
istered in all countries but one as a generic outcomemeasure.
In Australia with around 60 patients the SF-36 v2 was
applied with subsequently transformed data [16]. It is amulti-
item instrument with eight subscales assessing the following
domains: Physical Functioning (PF), Role Physical (RP),
Bodily Pain (BP), General Health (GH), Vitality (VT), Social
Functioning (SF), Role Emotional (RE), and Mental Health
(MH). For each domain, a summation of item responses
is linearly transformed into a score ranging from 0 to 100.
Additionally, a Physical Component Summary (PCS) and
a Mental Component Summary (MCS) score are reported.
PCS and MCS are calculated by standardizing patients’
scores through subtracting US subscale means from each
individual’s subscale scores. For more details, please look at
the manual [41].
2.5. Treatment of Missing Values. If less than one-third (33%)
of the items were missing, means for each QOLIBRI subscale
were calculated, prorated, and expressed as a score from 0
(lowest possible HRQoL measured by the questionnaire), to
100 (best possible HRQoL). A total QOLIBRI score was also
calculated as themean of all individual items, using prorating
if necessary. With the missing values in the SF-36 we dealt by
overall mean substitution per subscale. The missing values in
all other variables (correlates) were treated as missing.
2.6. Procedure. Between 2006 and 2008 individuals after
TBI were recruited primarily from rehabilitation clinics
or from convenience samples in all countries but one. In
Germany, patients were consecutively retrieved from com-
munity and university hospitals. Patients were identified
via archive search and contacted by mail. When interested
in participating they were contacted via telephone by the
recruiting centers. Upon initial contact, consent was obtained
from the participants and arrangements were made for the
completion of the questionnaires, considering the physical
and cognitive abilities, residence, and mobility constraints
of the participants. Those who were able to fill in the
questionnaires independently received questionnaires by
mail to be returned after completion. When participants
needed support, a face-to-face contact was arranged and the
GOSE and the inclusion/exclusion criteria were completed in
one interview. When postal administration was performed,
inclusion/exclusion criteria and the GOSE were completed in
a telephone interview. The GCS was then retrieved from the
patient record forms.
2.7. Data Analysis. Concerning the generic and disease-
specific HRQoL instruments (SF-36 and QOLIBRI, resp.)
classical psychometric criteria were investigated (mean, stan-
dard deviations (SD), skewness of item distribution, floor and
ceiling effects per scale, kurtosis, and Cronbach’s alpha, as
well as convergent and discriminant validity). Probabilistic
test theoretical analyses have already been applied for the
QOLIBRI [16]. Frequencies, means, SD, and percentages are
given for the covariates/correlates of HRQoL. Kolmogorov-
Smirnov [42] and Shapiro-Wilk test [43] were used to test if
the data were normally distributed. Ceiling and floor effects
were defined as answers which fell into the highest or lowest
10% of possible answers per subscale. These effects should
be minimal for an instrument to be able to discriminate
well.
To be able to investigate whether disease-specific and
generic HRQoL share similar correlates, the QOLIBRI Total
score and SF-36 MCS and PCS representing the outcomes
(predicted values) and a number of sociodemographic,
psychosocial, and health-related variables, known from the
literature as predictors and correlates, were submitted to a
stepwise linear regression analysis (SPSS 22.0). The variables
included in the first step were as follows: Years since Injury,
Age, Relationship Status, Education, Change of Job, Employ-
ment, Living Arrangement, the Degree of Help Needed,
Independence, Social Activities, Internet Activities and other
Hobbies, Comorbid Health Conditions, Sensory and Psy-
chosomatic and Motor-Skeletal Complaints, GOSE score,
and HADS Depression and Anxiety scores. As many of the
variableswere skewed, we ranked data before subjecting them
to regression analyses [44]. The criterion for inclusion of a
variable in the final model was that it should independently
explain 1% or more of the variance (increase in R2 > 1%) [17].
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2.8. Shannon Indices. Two different indices will be reported
in this paper, 𝐻󸀠 as the measure for absolute informativity
expressed by the number of categories tagged (addressed in
detail) and 𝐽󸀠 as a relative measure that takes into account
the maximum informativity which can be reached given a
certain number of categories.𝐻󸀠 is the absolute informativity
captured considering each predictor, whereas 𝐽󸀠 (evenness)
provides the relative informativity. A higher 𝐻󸀠 means that
more information is obtained. The evenness as a relative
measure is defined between 0 and 1. A high evenness value
indicates a uniform distribution of the response options for a
variable. A low evenness index is a sign of a skew distribution.
The Shannon index 𝐻󸀠 ([45]; see also [33–35]) was
calculated for the summary scores and for the separate
HRQoL dimensions/subscales. The basic characteristic of
Shannon’s indices can be explained as follows. In an itemwith
two response categories in which one response category has
a very high (or low) endorsement, for example, more than
0.95 (or less than 0.05), the response category transmits very
little information because one can predict with more than
95% certainty in what response category the answer will be
located [33]. Conversely, in the case of an even distribution,
the HRQoL dimension is being most efficiently used, which
means that the discriminant ability of the descriptors is
maximal. The Shannon index 𝐻󸀠 combines the number of
nonempty categories defined by a system and measures to
what extent the information is (empirically) evenly spread
over the nonempty categories. As stated above, the higher
the index 𝐻󸀠 is, the more the information is captured by
the system. However, the value of the index also depends
on the logarithm applied for calculation. Hence, when the
logarithm dualis is utilized values are higher than when
applying the logarithm naturalis. The logarithm base 2 is
defined by log(𝑝
𝑖
)/log(2), and in our case 𝑝
𝑖
is the probability
of a summary score. We calculated 𝐻󸀠 by the following
formula:
𝐻
󸀠
= −
𝐶
∑
𝑖=1
𝑝
𝑖
∗ log
2
𝑝
𝑖
. (1)
𝐶
𝑖
refers to the number of nonempty categories; 𝑝
𝑖
is the
probability of category 𝐶
𝑖
and log
2
is logarithm base 2. The
probability 𝑝
𝑖
of category 𝐶
𝑖
is estimated by the relative
frequencies defined by 𝑛
𝑖
/𝑁, where 𝑛
𝑖
is the frequency of
category 𝐶
𝑖
and𝑁 is the total number of cases. The Shannon
index𝐻󸀠 results from summing up the product 𝑝
𝑖
∗ log
2
(𝑝
𝑖
)
for all categories. In most cases, especially in information
theory, the formula of the Shannon index (SI) is calculated by
the natural logarithm and entropy is defined using logarithm
base 2. However, in HRQoL research SI has been defined
using logarithm base 2 in the formula [34]. In order to
assure continuity we decided to define the Shannon index by
logarithm base 2. Therefore, we also determined that each
score defined a category. After summing up the answers
of each person to an individual person score, these scores
were used as categories. No grouping was applied. 𝐻󸀠 max
is therefore estimated; it is defined as the maximum value of
𝐻
󸀠 (𝐻󸀠max = log
2
(𝐶
𝑖
)) and indicates the maximum available
information.The second index in the context of the Shannon
index is 𝐽󸀠 and is derived from 𝐻󸀠. 𝐽󸀠 presents a measure
for the spread of the frequencies or categories [34]. The
advantage of 𝐽󸀠, unlike 𝐻󸀠, is its independence from the
number of categories available in the dataset. Statistically,
𝐽
󸀠 quantifies how equally the numbers of categories are
distributed. So 𝐽󸀠, defined by 𝐽󸀠 = 𝐻󸀠/𝐻󸀠max, indicates how
close the number of different categories is. 𝐽󸀠 ranges between
0 and 1. The more 𝐽󸀠 deviates from 1, the less the scores are
evenly distributed.
Shannon indices were calculated for stratified groups
according to differential correlates of disease-specific and
generic HRQoL identified through regression analyses for
the summary scores and the different subscales of the two
instruments (see results section for details). QOLIBRI Total,
MCS, the PCS, and the respective subscales are compared
with respect to these different correlates of HRQoL. In order
to calculate𝐻󸀠 forMCS and PCS, we rounded up nonintegers
to build categories.
3. Results
3.1. Patients’ Clinical and Sociodemographic Data. Of the
921 enrolled patients 126 were excluded from subsequent
analyses as GCS were missing. Thus, for GCS and GOSE
100% of the data were present in the remaining 795 patients;
some additional data, however, were missing to different
degrees. For demographics concerning Gender and Age,
100% of the data were present and for Living Arrangements,
Employment Status, and Relationship Status 93% to 95.6%
were present. For Years since Injury 99% of the data was
available and 92% for self-reported health-related complaints.
HADS Anxiety and Depression scores existed for 99%, for
SF-36 subscales for about 91% before imputation. There were
less than 5%missing responses per QOLIBRI subscale before
imputation. Demographic and clinical characteristics of the
final validation study are presented in Table 1. In this TBI
sample (𝑁 = 795), there were a greater number of men
(𝑛 = 537) than women (𝑛 = 222). Within the age range
covered (from 17 to 68 years), three groups of almost equal
size were formed (17 to 30 years, 31 to 44 years, and 45 to 68
years).
The mean age was 39 years (SD ± 13.3 years). By GCS
criteria, more than half of the sample was severely injured,
and for 25% the injury had occurred between 2 to <4 and
for 49.6% between four years and 18 years earlier. Less than
a quarter of the sample was in full-time employment (which
cannot be taken as representative for other TBI samples)
and only half in a relationship at the time of the interview.
In the different countries, zero (Germany, Australia, and
England) to 45% of the patients were still undergoing some
kind of therapy or rehabilitation at the time of the assessment.
Over half of the TBI survivors were living independently
and did not “need help to carry out Daily Life tasks.”
Over half of the population reported four or more health-
related conditions concerning Comorbidity, Sensory and
Psychosomatic, and Motor-Skeletal Complaints. According
to the GOSE, the majority (72.4%) of participants were
disabled by consequences of their TBI (Severe and Moderate
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Table 1: Demographic and clinical characteristics of the TBI population.
Demographic and clinical variables Frequency (%)
Age
17–30 271 (34.1%)
31–44 247 (31.1%)
45–68 277 (34.8%)
Gender Male 573 (72.1%)
Female 222 (27.9%)
Time since injury
<1 year 93 (11.7%)
1 to <2 years 102 (12.8%)
2 to <4 years 203 (25.5%)
4 to 18 years 394 (49.6%)
Relationship Status Partnered 403 (50.7%)
Not partnered 303 (38.1%)
Highest Education level
Primary school 42 (5.3%)
Secondary school and trade or technical certificate 403 (50.7%)
College diploma or degree 173 (21.8%)
University degree 88 (11.1%)
Living
Living at home independently 420 (52.8%)
Living at home supported 245 (30.8%)
Nursing home 75 (9.4%)
Help Needed Yes 306 (38.5%)
No 427 (53.7%)
Leisure activities
Individual activities (internet + hobbies) 425 (53.5%)
Social activities (socializing + physical activities) 505 (63.5%)
Hobbies (hobbies + music) 395 (49.7%)
Health Complaints
Comorbidity 440 (55.3%)
Sensory/Psychosomatic 631 (79.4%)
Motor/Skeletal 363 (45.7%)
GCS
Severe (GCS < 8) 464 (58.4%)
Moderate (GCS 8–12) 76 (9.6%)
Mild (GCS ≥ 13) 255 (32.1%)
Glasgow Outcome Scale-Extended Score
Severe Disability (GOSE 3-4) 143 (17.9%)
Moderate Disability (GOSE 5-6) 433 (54.5%)
Good Recovery (GOSE 7-8) 219 (27.6%)
HADS Anxiety score
Normal 496 (62.4%)
Mild 144 (18.1%)
Moderate/Severe 152 (19.1%)
HADS Depression score
Normal 537 (67.5%)
Mild 120 (15.1%)
Moderate/Severe 132 (16.6%)
Disability). The mean period of follow-up was 5 years (SD ±
3.9).
3.2. Psychometric Analyses of QOLIBRI and the SF-36. As
data of the QOLIBRI as well as of the SF-36 (𝑃 < .001) were
not normally distributed, nonparametric tests were applied
[16, 17].
In this study additional psychometric criteria, as shown
in [16, 17], were investigated in order to compare the metric
qualities and the appropriateness of both instruments for
administration to individuals after TBI (Table 2).
Concerning item response distributions of the two instru-
ments, for the QOLIBRI subscales no extreme responses
(overall ≤20% of extreme responses), for example, no floor
or ceiling effects in the responses, were detected, except
for subscale Emotion with 24.7% of the answers ranging
from 90% to 100% very good to excellent HRQoL (ceiling
effects).The ceiling effect for the subscale Emotions had been
enhanced bymean imputation.The SF-36, on the other hand,
showed both types of effects in most of its subscales: RP
resulted in 26.3% responses with floor and 35.7% with ceiling
effects, RE had 24.4% floor and 46.2% ceiling effects, and PF,
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Table 2: Psychometric characteristics of the QOLIBRI and SF-36 subscales and summary scores.
Descriptive statistics Mean (SD) Floor [%] Ceiling [%] Skew Kurtosis Cronbach’s 𝛼
QOLIBRI
Physical Problems 67.91 (23.47) 1.4 15.2 .09 .02 .76
Emotions 71.71 (24.69) 2.9 24.5 −.87 .02 .84
Social Relationships 63.65 (22.64) 1.4 14.3 −.41 −.43 .82
Daily Life/Autonomy 66.41 (22.38) 1.3 14.5 −.61 −.11 .87
Self 60.03 (21.96) 2.1 6.2 −.42 −.31 .89
Cognition 61.26 (21.77) 1.0 7.2 −.42 −.34 .89
QOLIBRI Total 64.58 (18.24) 0.4 6.8 −.48 −.04 .82
SF-36
Role Physical 55.13 (38.84) 26.3 35.7 −.21 −1.42 .84
Physical Functioning 76.39 (23.75) 2.3 36.8 −1.15 .71 .93
Bodily Pain 71.28 (26.92) 2.5 36.4 −.61 −.58 .87
Role Emotional 61.01 (39.46) 24.4 46.2 −.46 −1.31 .82
Mental Health 63.90 (20.00) 1.1 8.8 −.46 −.08 .84
Social Functioning 68.01 (25.12) 2.2 22.4 −.59 −.15 .76
Vitality 54.63 (21.51) 4.4 6.5 −.27 −.16 .82
General Heath 63.60 (20.75) 1.1 11.7 −.35 −.33 .76
PCS 46.70 (10.13) 0 0 −.44 −.54 .91
MCS 43.91 (11.94) 0 0 −.40 −.59 .91
BP, and SF demonstrated 36.8%, 36.4%, and 22.4% ceiling
effects and considerably lower floor effects (see Table 2).
Table 2 indicates that psychometric properties of all
QOLIBRI and SF-36 subscales, as well for the QOLIBRI Total
score and MCS and PCS, were predominantly satisfactory to
very good. The two instruments differed in terms of skew,
kurtosis, and alpha values. Values for skew as well as for
kurtosis all fell within a tolerable range of ±2, which is
considered acceptable for a normal univariate distribution
[46]. Negative skew for all subscales (Table 2) reflected a
pronounced use of the right side of the scales. The latter was
confirmed by a significant Kolmogorov-Smirnoff test (𝑃 <
.001). Negative kurtosis denoted a flat distribution across all
scales with a more pronounced peak to the right as indicated
by negative skew. Subscales RF, RE, and SF of the SF-36 were
characterized by floor/ceiling effects, as displayed in Table 2,
withmore than 50% of the responses for the subscales RP and
RE located at the extremes of the answering scales. Cronbach’s
alpha for both instruments ranged from 𝛼 = .76 to .93 which
is considered good to excellent [47].
3.3. Correlates of Disease-Specific and Generic HRQoL. To
answer the question whether correlates of disease-specific
and generic HRQoL do differ, the following variables from
the final stepwise regression models for the total score of the
QOLIBRI and the summary scores of SF-36 were selected
for further analyses: HADS Depression, HADS Anxiety,
Help Needed, Social Activities, Comorbidities, Sensory and
Psychosomatic Complaints, Motor-Skeletal Complaints, and
GOSE categories. With regression analyses in psychometric
terms predictors of HRQoL are identified. However, in order
to enhance interdisciplinary comprehensibility, we are using
the term correlates of HRQoL even though these were
identified by multiple regression analyses and not by simple
correlation analyses.
The strongest correlates of the QOLIBRI Total score
were aspects of the current emotional situation, namely,
in descending sequence: HADS Anxiety (27.9%), HADS
Depression (10.8%), Functional Outcome (GOSE) (6.3%),
Sensory and Psychosomatic Complaints (2.2%), Degree of
Help Needed (1.6%), and Social Activities (1%).The strongest
correlates for MCS of the SF-36 were HADS Depression
(30.5%), HADS Anxiety (9.8%), and Sensory and Psy-
chosomatic Complaints (1.4%), which qualified for further
analyses. The strongest correlates for the PCS were Motor-
Skeletal Complaints (22%), Comorbidities (6.1%), Degree
of Help Needed (5.4%), and Social Activities (3%), as well
as Functional Outcome (GOSE) (1.8%), and hence those
were suitable for further analysis (Table 3). As expected,
the correlates of MCS had mental/psychological aspects in
common, and the correlates of PCS captured physical aspects.
The correlates of QOLIBRI Total score on the other hand
represented a mix of both.
3.4. Shannon Indices of Disease-Specific and Generic HRQoL.
Here the discriminative power of the two instruments by
means of the Shannon index 𝐻󸀠 was calculated, as was the
evenness index 𝐽󸀠. 𝐽󸀠 was close to 1 for all Shannon indices
𝐻
󸀠, indicating a uniform distribution of data. However, since
the range and directionality of the 𝐽󸀠 results did not essentially
deviate from𝐻󸀠, that is, they were comparable, 𝐽󸀠 (.64 to .97)
was not considered for further analyses (data available upon
request).
As high Shannon indices indicate high informativity
the results clearly showed that SF-36 subscales RP (2.17),
RE (1.83), and SF (2.01) had a significantly lower Shannon
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Table 3: Results of the stepwise regression analysis.
Dependent variable Proportion of explained variance Change in 𝑅2 Significance of change in 𝑅2
QOLIBRI Total
HADS Anx. .278 .279 .000
HADS Dep. .385 .108 .000
GOSE .447 .063 .000
Sensory/Psychosom. .468 .022 .000
Help Needed .483 .016 .000
Soc. Act. .492 .010 .001
SF-36-MCS
HADS Dep. .303 .305 .000
HADS Anx. .401 .098 .000
Sensory/Psychsom. .414 .014 .001
SF-36-PCS
Motor/Skeletal .218 .220 .000
Comorbidity .278 .061 .000
Help Needed .331 .054 .000
Soc. Act. .359 .030 .000
GOSE .376 .018 .000
index/grade of informativity (ranging from 1.83 to 2.17) as
well as 𝐻󸀠 of BP (2.82) in comparison to all other subscales.
The Shannon index of the PF was above 3.5, and for MCS
and PCS it was above 5. In contrast, all Shannon indices
of the QOLIBRI were around 4 (ranging from 3.90 to 4.83)
indicating a high discriminative power of all subscales and
the total score. As seen in Figure 3, the Shannon indices of
PCS and MCS were high. These values can be explained by
the great number of categories used in these two summary
scales applied for calculation of𝐻󸀠.
Next, we inspected the𝐻󸀠 index (diversity/absolute infor-
mativity) with respect to the two HRQoL instruments for the
single correlates in detail.
With respect to Help Needed and Social Activities, the
QOLIBRI subscales differentiated well within the correlates,
with 𝐻󸀠 ranging from Physical Problems 3.76 to 4.75 total
QOLIBRI. The SF-36 subscales RP, SF, and RE, as expected,
did not discriminate well within the correlates (with lowest
indices for RE <2); the summary scores MCS and PCS
however did differentiate well (with highest index of 5.11 for
MCS). Unlike theQOLIBRI subscales, the SF-36 subscales PF
and BP differed significantly in their informativity for Help
Needed and Social Activities.
Absolute Shannon indices 𝐻󸀠 of all QOLIBRI subscales
indicated that for the three health complaints all differenti-
ated better than did the SF-36 subscales in the whole sample.
The Shannon indices 𝐻󸀠 for the summary scores MCS and
PCS, however, were significantly higher than for all other
subscales and for the total QOLIBRI score. The subscale
Physical Problems (QOLIBRI) transmitted more absolute
informativity concerning the single individuals in all three
groups of self-reported health complaints than did RP and
BP of SF-36. Yet, the informativity of the PF was comparable
to the Physical Problems scale of the QOLIBRI.
The Shannon indices 𝐻󸀠 for the RP, RE, and SF repro-
duced the same pattern as in Figures 1–3 with low informa-
tivity concerning individuals belonging to the specific GOSE
groups compared to all other scales and summary scores
(Figure 4). The QOLIBRI indices, however, ranged from
3.64 (Physical Problems) to 4.57 (Self). Within the QOLIBRI
subscales Emotions, Social, Daily Life, Self, and Cognition,
the Shannon indices differentiated in theModerate Disability
GOSE category better than in the Good Recovery category,
whereby the latter index was lower.
For RP, PF, RE, PCS, andMCS the SF-36 results in a higher
informativity for Moderate Disability over Good Recovery.
In addition, informativity of MCS and PCS was significantly
higher for Moderate Disability than for Severe Disability and
significantly differed between Severe andModerate Disability
and between Moderate Disability and Good Recovery.
The Shannon indices𝐻󸀠 for all QOLIBRI scores (ranging
from 3.69 for Physical Problems to 4.51 for QOLIBRI Total)
and the three GOSE scores were generally higher than for
the SF-36 subscales (Figure 4). The Shannon indices did
not differ between the score categories per subscale. In the
SF-36 subscales, however, we observed considerably more
variability.The𝐻󸀠 indices range from 1.66 (RE) to 5.14 (MCS).
Within the SF-36 subscales, the indices differed significantly
for RP with a higher 𝐻󸀠 for Mild Depression as for Normal
and Moderate/Severe Depression. Also, the subscales PF, BP,
and RE presented significantly different patterns: HADSMild
andModerate/SevereDepression scores differed significantly,
as did Moderate/Severe and Normal Depression scores but
Mild and Normal Depression scores did not.The subscale PF
showed the highest𝐻󸀠 index forModerate/SevereDepression
scores being, along with the Mild Depression scores, signif-
icantly higher than the Normal Depression score 𝐻󸀠 index.
For BP, the Moderate/Severe Depression score was different
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Figure 1: Shannon indices 𝐻󸀠 (confidence intervals 95%) of all
QOLIBRI and SF-36 subscales, QOLIBRI Total score and summary
scores.
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Figure 2: Shannon indices 𝐻󸀠 (confidence intervals 95%) of all
QOLIBRI and SF-36 subscales, QOLIBRI Total score and MCS and
PCS for the correlates: Help Needed and Social Activities.
from theNormal Depression score with the highest𝐻󸀠 index.
For subscale RE, the Mild Depression score presented with
the highest𝐻󸀠 index and differentiated significantly between
Normal and Moderate/Severe Depression scores. All other
indices were comparable to each other (Figure 5).
Also with regard to the HADS three levels of anxiety, the
QOLIBRI was characterized by higher indices than the SF-
36. The QOLIBRI subscale indices range from 3.39 (Physical
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Figure 3: Shannon indices 𝐻󸀠 (confidence intervals 95%) of all
QOLIBRI and SF-36 subscales, QOLIBRI Total score and MCS and
PCS for the correlates: Comorbidity, Sensory/Psychosomatic and
Motor/Skeletal Complaints.
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Figure 4: Shannon indices 𝐻󸀠 (confidence intervals 95%) of all
QOLIBRI and SF-36 subscales, QOLIBRI Total score and MCS and
PCS for the correlate GOSE scores.
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Figure 5: Shannon indices 𝐻󸀠 (confidence intervals 95%) of all
QOLIBRI and SF-36 subscales, QOLIBRI Total score and MCS and
PCS for the correlate HADS Depression scores.
Problems) to 4.63 (Daily Life).The Shannon indices𝐻󸀠 of the
subscales between the score categories were comparable. The
subscales of the SF-36 resulted in indices ranging from 1.57
(RE) to 4.04 (PF) and to 5.01 for the PCS. Within the SF-36
subscales, the indices differed for RE, with 𝐻󸀠 for the Mild
Anxiety score being higher than the Normal Anxiety score,
PF and BP between Moderate/Severe and the Normal score
(Figure 6).
4. Discussion and Conclusions
The aim of this paper was a detailed investigation of classical
psychometric criteria and the discriminative power/absolute
informativity of a disease-specific (QOLIBRI) and a generic
(SF-36) HRQoL instrument in the field of TBI.
Psychometric properties of both instruments in a TBI
sample were satisfactory to very good, in this and in pre-
vious studies. Both instruments are valid and reliable. Item
distribution of the QOLIBRI showed no floor effects, but
some ceiling effects for the Emotional subscale. For the SF-
36 prominent floor (RP, RE) and ceiling effects (RP, PF, BP,
RE, and SF) were identified for the majority of subscales.
These effects may already indicate that the subscales of the
SF-36 might not differentiate sufficiently in a population of
TBI survivors.
When comparing the mean values of PCS and MCS with
those found in the literature, an overarching effect becomes
apparent. In the study of Scholten et al. [48], for example,
patients have lower PCS (M = 45, SD = ±10.1) than MCS
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Figure 6: Shannon indices 𝐻󸀠 (confidence intervals 95%) of all
QOLIBRI and SF-36 subscales, QOLIBRI Total score and PCS and
MCS for the correlate HADS Anxiety scores.
values (M = 47.2, SD = ±11.6). This pattern is confirmed by
Forslund et al. [49], Jacobsson et al. [50], and Grauwmeijer et
al. [51]. The latter argued that this finding might be ascribed
to the limited awareness of patients after severe TBI who
participated in their sample. For our study the results of MCS
and PCS are reversed: Values for the PCS (M = 46.70, SD =
±10.1) are higher than for the MCS (M = 43.9, SD = ±11.9).
Hawthorne et al. [12] found similar results in mild TBI.These
individuals may be less impaired by awareness problems,
which subsequently could result in lower MCS values. How-
ever, in our study the number of patients who had sustained a
severe TBIwas twice as large as thosewho had endured amild
TBI. Thus, these findings have to be analysed in more detail
in further studies. A Structural Equation Modeling (SEM)
approach incorporating the covariates identified within this
study may facilitate understanding of these interactions. In
general a measure of awareness can be recommended [52]
to scrutinize the relationship between HRQoL ratings in
the field of TBI. When comparing the QOLIBRI subscale
means and the total score to other studies applying it,
mean values are comparable across studies [20–22]. The
highest score was determined for the subscale Emotions,
followed by Physical Problems. Lower scores were found for
Cognition and lowest for the subscale Self. High scores in the
subscale Emotions could have been influenced by negative
wording, the reversing/recoding of the answers, and the use
ofmean imputationmethod. Initially employed to counteract
acquiescence response style, empirical evidence exists that
reverse coding may actually impair response accuracy [53].
Subsequently, the high scores for the subscale Emotions are
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not likely to be due to an awareness problem of the patients,
especially since the scale Cognition (not reversely scored)
presents low values, indicating that an overestimation of
cognitive capacities is not present.
Differences observed between the means of the SF-36
and the QOLIBRImay be confounded by different evaluation
and/or scoring methods of the instruments. First of all, there
are important differences in the applied health/HRQoL state
evaluation technique: In the SF-36 response options vary
frombinary to a six-point Likert scale andweighted summary
scale scores.The QOLIBRI in contrast consists of a five-point
Likert response and a simple summed up total score.
To investigate the relationship between the instruments
applied and the sociodemographic as well as clinical vari-
ables, via stepwise regression analyses, correlations of the
PCS, MCS (SF-36), and the QOLIBRI Total score were
performed. The following correlates of disease-specific and
generic HRQoL were identified: for the PCS: Motor/Skeletal
Complaints, Comorbidity, Help Needed, Social Activi-
ties, GOSE; for MCS: HADS Depression and Anxiety
and Sensory/Psychosomatic Complaints. For the QOLIBRI
Total score HADS Anxiety and Depression, GOSE, Sen-
sory/Psychosomatic Complaints, Help Needed, and Social
Activities correlates were identified. Only a small number
of studies use a comparable comprehensive approach for
the identification of correlations. Soberg et al. [20] selected
correlates for disease-specific HRQoL bymultiple regression:
the HADS evolved as the most relevant, followed by RPQ,
GOSE after 12 months, GOSE after 3 months, and Employ-
ment Status. These results correspond partly to ours. We
share the authors’ assumption that the association between
injury severity andHRQoLmay dissolve over time, as we also
did not find a relationship to GCS in a previous univariate
analysis [17]. For over 60% of individuals in our sample
the injury had occurred 2 to 18 years prior to participation
in the study. In our initial calculations, “time since injury”
resulted in significant effects only on three subscales of the
questionnaires, for QOLIBRI (Cognition, Self, and Social
Relationships) and the SF-36 (RP, BP, and GH). Due to space-
constraints, we decided not to focus on time since injury in
more detail in this paper. However, the importance of other
variables (e.g., psychological and social components) may
increase for HRQOL at the later stages of injury.
Since HRQoL is a multifaceted dynamic process affected
by many different factors [53] further research with extended
correlate models is required. Single correlates such as Func-
tional Recovery, Anxiety/Depression, Race, Gender, and
Severity of TBI have been investigated, showing detrimental
effects on genericHRQoL in different settings and for varying
degrees of severity [27, 51, 54–56].Unfortunately, in our paper
the influence of higher order factors could not be investigated
with the analyses applied. A hierarchical linear model will
most likely be able to shed light on the complex interplay of
variables on different levels.
Subsequently, we discuss our results with respect to
differentiating individuals contained in one health state or
HRQoL dimension, presented by the Shannon index (𝐻󸀠).
The SF-36 data implied that the three subscales RF, RP, and
RE generally did not have good discriminative power. 𝐻󸀠 of
the remaining SF-36 subscales as well as the two summary
scores discriminated well in our TBI population. On the
other hand, all QOLIBRI scores displayed high Shannon
indices, a result which underlines the necessity of applying
specifically tailored instruments to certain diseases. Whereas
the generic SF-36 can be used for cross-disease comparisons,
the QOLIBRI focuses on consequences important for TBI
survivors. Consequently, it should have higher discrimina-
tory power in a specific disease group, which is supported by
the results presented within this study. Even though this was
not assessed in the present study, but will be in future ones,
higher discriminatory power of the QOLIBRI could result in
higher sensitivity of this instrument.
As the SF-36 is known to discriminate well between
different health/HRQoL states/dimensions in TBI [5], these
differences in Shannon indices may initially seem contrain-
tuitive and surprising. Inspecting the response distribution
in corresponding individual items and subscales we have
however determined pronounced floor and ceiling effects in
many of the SF-36 subscales but not for the QOLIBRI. These
effects resulted in lower Shannon indices, as frequencies
have an impact on the calculation of 𝐻󸀠. Therefore, these
subscales seem to be less sensitive in detecting differences
within certain TBI subgroups, when compared to all scores
of the QOLIBRI.
TBI outcome is heterogeneous, encompassing a broad
spectrum of HRQoL with many problems reported in the
physical, emotional, and social functioning domain. In the
field of TBI—as in nearly all other medical fields—there
is a lack of consensus on preferred HRQoL instruments.
To enable straightforward comparisons with other disease
groups and with general population norms, it is necessary to
measure the consequences of TBI using generic health status
measures (as the SF-36 or the EQ-5D) [35]. However, the
domains may be not specifically relevant for TBI survivors,
as can be deduced from many of our results. There are other
important problems that are often identified to be common in
TBI, such as cognitive consequences [57], alterations in social
relationships [58], limitations to activity and participation
[59], changes in the sense of self [60], emotional problems
[61], and physical problems. HRQoL in some of these areas
typically affected by TBI is not well assessed or not assessed at
all by generic HRQoL instruments. In contrast, the QOLIBRI
captures multiple of these domains, encompassing especially
the psychological (emotional and cognitive), social, and also,
to a lesser extent than the SF-36, physical and functional
domains [6, 17]. The use of SF-36 in combination with the
QOLIBRI is recommended, depending on the focus of a
study. For in-group discrimination of patients, requiring a
specifically tailored health intervention, the QOLIBRI should
be the tool of choice. For comparison and differentiation of
individuals between certain health states, health conditions,
or HRQoL domains, the SF-36 is an appropriate instrument
also. Consensus on preferred methodologies of HRQoL
assessment in TBI would facilitate comparability across
studies, resulting in improved understanding of recovery and
the burden of TBI.
Limitations of the reported study are inherent to the com-
parison of generic and disease-specific HRQoL instruments.
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Individual subscales are not directly comparable, as they con-
sist of a different number of subscales and a different number
and content of items per subscale, which are not always based
on the same theoretical concept. Therefore 𝐻󸀠 was applied
for comparison. Another limitation may be due to the use
of version 1 of the SF-36 in this study because of being
available in the public domain. Some of the psychometric
problems however, especially concerning the physical scales,
are described to be solved in version 2 of the instrument
[62]. Thus, Shannon indices of the SF-36 v2 subscales remain
to be investigated. The currently conducted prospective
longitudinal Center-TBI study (https://www.center-tbi.eu/)
will allow for this. Furthermore, the influence between the
correlates selected and HRQoL could not be investigated in
this paper. A Structural EquationModeling (SEM) approach,
as proposed by Williamson et al. [63], could determine
whether the correlates are of importance on a precedent
level. Interestingly, in recent years many experts refer to
TBI as a chronic disease [64], according to whom TBI
should be also managed as such. If this chronic nature of
TBI is recognized, research could be directed at discovering
therapies that may interrupt the disease processes months or
even years after the initial event. This paradigm shift would
also have an impact on the importance of measuring HRQoL
after TBI. Strengths of the study however lie in the attempt to
embark in this comparison with a rather new methodology.
Shannon indices were calculated in a large number of TBI
survivors of all severity levels after applying a comprehensive
regression model. In line with our expectations, HRQoL
differed depending onGOSE recovery andHADSDepression
scores.TheQOLIBRI subscales and total score detectedmore
differences between the levels of recovery and depression
than the SF-36. In accordance with most studies, lowest
HRQoL was observed for severe/moderate depression as
well as severe disability. Consistently, HRQoL increased
for patients with only Mild Depression and good recovery
[30, 65]. Finally, there is a need for longitudinal studies
that evaluate possible differential effects over time (such as
Center-TBI and Track-TBI). It may well be that correlates are
quite different at different time periods after injury.
5. Conclusion
Differential correlates were identified for generic and specific
HRQoL. In order to better understand HRQoL of patients
after TBI, we would like to accentuate a comprehensive
assessment of correlates and the use of SEM for future
studies. The complex interplay of these factors has to be
scrutinized to ameliorate symptoms and tailor interventions
for TBI survivors. Based on our novel investigation of the
power to discriminate individuals in a health state or in a
HRQoL dimension with the Shannon indices 𝐻󸀠 and 𝐽󸀠 in
comparison with the SF-36, the QOLIBRI is recommended
for assessment.
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